Research Article

Utilizing Pulsed Electromagnetic Field (PEMF) Therapy (Diapulse®) for Drug- Free Pain Management to Eliminate Reliance on Opioids for Non-Malignant Chronic Pain: A literature Review and Proposal for Pilot Study

Thomas A Sharon

Published: 06/17/2019 | Volume 3 - Issue 1 | Pages: 027-034


The Federal and State governments have declared the presence of an opioid addiction pandemic in the United States claiming the lives of more than 55,000 in 2015 (Rudd RA, Seth P, David F and Scholl L. 2016). The pharmaceutical manufacturers of the numerous FDA-approved opioid drugs are raking in more than $5 billion per year with about 2 million chronic pain sufferers addicted. The irony of this narcotic use and abuse conundrum is the existence of evidence-based technology for drug-free pain management which is not covered for reimbursement among public and private third-party payers. Therefore, this paper is presented to propose a pilot study to demonstrate the efficacy of resolving the chronic inflammation, edema and ischemia that causes non-malignant chronic pain with PEMF therapy, a non-invasive, non-thermal radio transmission of electrical impulses, thereby invalidating the legitimacy of prescribing opioid analgesics in such cases.

Read Full Article HTML DOI: 10.29328/journal.cjncp.1001013 Cite this Article


  1. Lyapustina T, Alexander CG. The prescription opioid addiction and abuse epidemic: how it happened and what we can do about it. The Pharmaceutical Journal. 2015; 11: 1-9. Ref.:
  2. Van Zee A. The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy. Am J Public Health. 2009; 99: 221-227. Ref.:
  3. Rudd RA, Seth P, David F, Scholl L. Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015. Morbidity and Mortality Weekly Report US Department of Health and Human Services/Centers for Disease Control and Prevention. 2016; 65: 1445-1452. Ref.:
  4. Gostin LO, Hodge JG, Noe SA. Reframing the Opioid Epidemic as a National Emergency. JAMA. 2007; 318: 1539-1540. Ref.:
  5. Harper WL, Schmidt WK, Kubat NJ, Isenberg RA. An open-label pilot study of pulsed electromagnetic field therapy inthe treatment of failed back surgery syndrome pain. Int Med Case Rep J. 2015; 8: 13-22. Ref.:
  6. Reddy RS. Effect of pulsed electromagnetic field therapy on pain, pressure pain threshold, and pain-free grip strength in participants with lateral epicondylitis. Saudi J Sports Med. 2017; 7: 93-96. Ref.:
  7. Rohde CH, Taylor EM, Alonso A, Ascherman JA, Hardy KL. et al. Pulsed Electromagnetic Fields Reduce Postoperative Interleukin – 1β, Pain, and Inflammation: A Double-Blind, Placebo-Controlled Study in TRAM Flap Breast Reconstruction Patients. Plast Reconstr Surg. 2015; 135: 808e-817e. Ref.:
  8. Graak V, Chaudhary S, Bal BS, Sandhu JS. Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy. Int J Diabetes Dev Ctries. 2009; 29: 56-61. Ref.:
  9. Bagnato GL, Miceli G, Marino N, Sciortino D, Bagnato GF. Pulsed electromagnetic fields in knee osteoarthritis: adouble blind, placebo-controlled, randomized clinicaltrial. Rheumatology. Rheumatology (Oxford) 2015; 55: 755-762. Ref.:
  10. Sharon TA. An Investigation of the Effects of Pulsed Electromagnetic Field Therapy on Plantar Skin Blood Perfusion in People with Diabetes Mellitus Type 2: A Pilot Study. 2015; 3732465. Ref.:
  11. Schneiderhan J, Clauw D, Schwenk TL. Primary Care of Patients with Chronic Pain. JAMA. 2017; 317: 2367-2368. Ref.: